Advertisement
U.S. markets open in 1 hour 14 minutes

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
7.65-0.14 (-1.80%)
At close: 04:00PM EDT
7.28 -0.37 (-4.84%)
After hours: 06:24PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
97,243
86,455
7,686
6,308
1,114,200
-
Cost of Revenue
4,400
2,159
813
553
565
-
Gross Profit
92,843
84,296
6,873
5,755
1,113,635
-
Operating Expense
542,352
630,759
553,862
466,664
489,666
-
Operating Income
-449,509
-546,463
-546,989
-460,909
623,969
-
Net Non Operating Interest Income Expense
37,374
38,743
14,190
2,883
9,597
-
Other Income Expense
-33,538
-33,769
15
134
-27,493
-
Pretax Income
-445,673
-541,489
-532,784
-457,892
606,073
-
Net Income Common Stockholders
-445,673
-541,489
-532,784
-457,892
606,073
-
Diluted NI Available to Com Stockholders
-445,673
-541,489
-532,784
-457,892
606,073
-
Basic EPS
-12.71
-9.05
-8.98
-7.80
11.66
-
Diluted EPS
-12.71
-9.05
-8.98
-7.80
11.43
-
Basic Average Shares
48,343
59,836
59,306
58,670
51,983
-
Diluted Average Shares
48,343
59,836
59,306
58,670
53,003
-
Total Operating Income as Reported
-482,895
-579,849
-546,989
-460,909
596,226
-
Total Expenses
546,752
632,918
554,675
467,217
490,231
-
Net Income from Continuing & Discontinued Operation
-445,673
-541,489
-532,784
-457,892
606,073
-
Normalized Income
-412,287
-508,103
-532,784
-457,892
633,816
-
Interest Income
37,374
38,743
14,190
2,883
9,597
-
Net Interest Income
37,374
38,743
14,190
2,883
9,597
-
EBIT
-449,509
-546,463
-546,989
-460,909
623,969
-
EBITDA
-448,123
-545,070
-545,867
-456,727
626,599
-
Reconciled Cost of Revenue
4,400
2,159
813
553
565
-
Reconciled Depreciation
1,386
1,393
1,122
4,182
2,630
-
Net Income from Continuing Operation Net Minority Interest
-445,673
-541,489
-532,784
-457,892
606,073
-
Total Unusual Items Excluding Goodwill
-33,386
-33,386
0
0
-27,743
-
Total Unusual Items
-33,386
-33,386
0
0
-27,743
-
Normalized EBITDA
-414,737
-511,684
-545,867
-456,727
654,342
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
0
0
0
0
0
-